Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).
aap postpones publication of the consolidated financial statements 2023 due to staff shortages – Biotech Investments
aap Implantate AG / Key word(s): Annual Report aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages 17-Apr-2024